Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555588 · ClinicalTrials.gov registry record · NA
Engage Psychosocial Intervention for Cancer Symptoms
A NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT06555588: Recruiting NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma, sponsored by Duke University.
NCT06555588 is a NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma that is actively recruiting participants, run by Duke University. The registered enrollment target is 190 participants, below the 458-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06555588, a NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.
Primary Outcome
This measure assesses the degree to which, over the past 7 days, symptoms of pain, fatigue, and/or distress have interfered with patients' general activity, mood, work (including work around the house), relations with other people, walking, and enjoyment of life. Items are scored from 0 = "Did not interfere" to 10 = "Interfered completely," and averaged for a composite score.
Conditions Studied
Interventions
- BEHAVIORAL ENGAGE
- BEHAVIORAL Supportive Care
Study Locations (1)
North Carolina
- Duke Cancer Network - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2028-11 |
| Phase | NA |
What NCT06555588 shows while recruiting
NCT06555588 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 458-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (59% lower).
The record links to 5 conditions, with Advanced Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which ENGAGE is the first listed.
NCT06555588 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06555588 about?
NCT06555588 is a clinical study titled "Engage Psychosocial Intervention for Cancer Symptoms". The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes wil...
What is the current status of trial NCT06555588?
This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2025-06-11. Estimated completion is 2028-11.
What conditions does trial NCT06555588 study?
This clinical trial studies the following conditions: Advanced Breast Cancer, Advanced Colorectal Carcinoma, Advanced Prostate Cancer, Advanced Lung Cancer, Advanced Colorectal Adenocarcinoma.
What interventions are being tested in trial NCT06555588?
The interventions under investigation include: ENGAGE (BEHAVIORAL), Supportive Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06555588?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555588 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06555588's enrollment target sits among peer trials
190 16th of 28 higher than 13 of 28 other Advanced Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The COMPASSION Study
RECRUITING · NA
-
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
RECRUITING · NA
-
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer
COMPLETED · NA
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
-
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI